| Cold atmospheric plasma-treated PBS eliminates immunosuppressive pancreatic stellate cells and induces immunogenic cell death of pancreatic cancer cells J Van Loenhout, T Flieswasser, L Freire Boullosa, J De Waele, ... Cancers 11 (10), 1597, 2019 | 96 | 2019 |
| Prognostic and predictive aspects of the tumor immune microenvironment and immune checkpoints in malignant pleural mesothelioma E Marcq, V Siozopoulou, J De Waele, J van Audenaerde, K Zwaenepoel, ... Oncoimmunology 6 (1), e1261241, 2017 | 88 | 2017 |
| Cold atmospheric plasma treatment of melanoma and glioblastoma cancer cells S Vermeylen, J De Waele, S Vanuytsel, J De Backer, J Van der Paal, ... Plasma Processes and Polymers 13 (12), 1195-1205, 2016 | 76 | 2016 |
| The CD70-CD27 axis in oncology: the new kids on the block T Flieswasser, A Van den Eynde, J Van Audenaerde, J De Waele, ... Journal of experimental & clinical cancer research 41 (1), 12, 2022 | 73 | 2022 |
| Interleukin-15 stimulates natural killer cell-mediated killing of both human pancreatic cancer and stellate cells JRM Van Audenaerde, J De Waele, E Marcq, J Van Loenhout, E Lion, ... Oncotarget 8 (34), 56968, 2017 | 65 | 2017 |
| Abundant expression of TIM-3, LAG-3, PD-1 and PD-L1 as immunotherapy checkpoint targets in effusions of mesothelioma patients E Marcq, J De Waele, J Van Audenaerde, E Lion, E Santermans, N Hens, ... Oncotarget 8 (52), 89722, 2017 | 60 | 2017 |
| Poly (I: C) primes primary human glioblastoma cells for an immune response invigorated by PD-L1 blockade J De Waele, E Marcq, JRM Van Audenaerde, J Van Loenhout, C Deben, ... Oncoimmunology 7 (3), e1407899, 2018 | 50 | 2018 |
| Cancer-associated fibroblasts as a common orchestrator of therapy resistance in lung and pancreatic cancer A Domen, D Quatannens, S Zanivan, C Deben, J Van Audenaerde, ... Cancers 13 (5), 987, 2021 | 47 | 2021 |
| Natural killer cells and their therapeutic role in pancreatic cancer: A systematic review JRM Van Audenaerde, G Roeyen, PK Darcy, MH Kershaw, M Peeters, ... Pharmacology & therapeutics 189, 31-44, 2018 | 46 | 2018 |
| Clinically relevant chemotherapeutics have the ability to induce immunogenic cell death in non-small cell lung cancer T Flieswasser, J Van Loenhout, L Freire Boullosa, A Van den Eynde, ... Cells 9 (6), 1474, 2020 | 43 | 2020 |
| Macrophage miR-210 induction and metabolic reprogramming in response to pathogen interaction boost life-threatening inflammation F Virga, F Cappellesso, B Stijlemans, AT Henze, R Trotta, ... Science advances 7 (19), eabf0466, 2021 | 28 | 2021 |
| Novel combination immunotherapy for pancreatic cancer: potent anti‐tumor effects with CD40 agonist and interleukin‐15 treatment JRM Van Audenaerde, E Marcq, B von Scheidt, AS Davey, AJ Oliver, ... Clinical & translational immunology 9 (8), e1165, 2020 | 28 | 2020 |
| Tissue‐specific tumor microenvironments influence responses to immunotherapies AJ Oliver, AS Davey, SP Keam, S Mardiana, JD Chan, B von Scheidt, ... Clinical & translational immunology 8 (11), e1094, 2019 | 27 | 2019 |
| Targeting hedgehog signaling in pancreatic ductal adenocarcinoma D Quatannens, Y Verhoeven, P Van Dam, F Lardon, H Prenen, G Roeyen, ... Pharmacology & Therapeutics 236, 108107, 2022 | 25 | 2022 |
| The search for an interesting partner to combine with PD-L1 blockade in mesothelioma: focus on Tim-3 and LAG-3 E Marcq, JRM Van Audenaerde, J De Waele, C Merlin, P Pauwels, ... Cancers 13 (2), 282, 2021 | 21 | 2021 |
| The effect of local non‐thermal plasma therapy on the cancer‐immunity cycle in a melanoma mouse model A Lin, J De Backer, D Quatannens, B Cuypers, H Verswyvel, ... Bioengineering & Translational Medicine 7 (3), e10314, 2022 | 16 | 2022 |
| Building a bridge between chemotherapy and immunotherapy in malignant pleural mesothelioma: investigating the effect of chemotherapy on immune checkpoint expression E Marcq, JRM Van Audenaerde, J De Waele, J Jacobs, J Van Loenhout, ... International journal of molecular sciences 20 (17), 4182, 2019 | 11 | 2019 |
| Humoral and cellular immune responses against SARS-CoV-2 after third dose BNT162b2 following double-dose vaccination with BNT162b2 versus ChAdOx1 in patients with cancer Y Debie, JRM Van Audenaerde, T Vandamme, L Croes, LA Teuwen, ... Clinical Cancer Research 29 (3), 635-646, 2023 | 9 | 2023 |
| Targeting CD70 in combination with chemotherapy to enhance the anti-tumor immune effects in non-small cell lung cancer T Flieswasser, A Van den Eynde, L Freire Boullosa, J Melis, C Hermans, ... Oncoimmunology 12 (1), 2192100, 2023 | 3 | 2023 |
| Immunogenic Potential Of Cold Atmospheric Plasma For The Treatment Of Pancreatic Cancer J Van Loenhout, C Deben, J Jacobs, J De Waele, J Van Audenaerde, ... Clinical Plasma Medicine 9, 26, 2018 | 3 | 2018 |
Evelien SmitsProfessor at University of Antwerp, BelgiumGeverifieerd e-mailadres voor uantwerp.be
